Optiver Holding’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
Other funds holding CRDF
LCM
P
Optiver Holding's CRDF Position: Q2 2026 in Review
Optiver Holding increased its Cardiff Oncology (CRDF) stake by 513% in Q2 2026, buying an estimated $13.5K and bringing the position to 10,151 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1672.
Optiver Holding first reported a position in CRDF in Q3 2025 and has held it in 3 quarters since. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.
- Optiver Holding held 10,151 shares of Cardiff Oncology worth $13.2K as of Q2 2026.
- Optiver Holding bought 8,494 Cardiff Oncology shares in Q2 2026, an estimated $13.5K.
- Cardiff Oncology made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1672 holding.
- Optiver Holding first reported a position in Cardiff Oncology in Q3 2025 and has held it in 3 quarters since.
- 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.
Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.